cefuroxime has been researched along with Lupus Erythematosus, Systemic in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uz, E | 1 |
| Bavbek, N | 1 |
| Turgut, FH | 1 |
| Kanbay, M | 1 |
| Kaya, A | 1 |
| Akcay, A | 1 |
1 other study available for cefuroxime and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Cefuroxime-induced lupus.
Topics: Anti-Bacterial Agents; Cefuroxime; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged | 2007 |